SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SANUWAVE Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.83−0.13 (-2.62%)
Close on Oct 19, 2026
- Market cap
- $41.54M
- P/E (TTM)
- 11.8
- Dividend yield
- –
SANUWAVE Health, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| System revenue | $16.37M | $17.53M | $17.85M | $14.96M | $14.23M | $12.90M | $11.07M | – | – | – | – | – | 37.2% | +15.0% |
| System revenue | – | – | – | – | – | – | – | $9.21M | $7.17M | $6.46M | $5.96M | $6.82M | – | – |
| License fees and other | – | – | – | $30.00K | $35.00K | $40.00K | $40.00K | – | – | – | – | $423.00K | – | – |
| Consumables and parts revenue | – | – | – | $26.06M | $24.66M | $22.92M | $21.14M | $19.40M | $16.94M | $14.92M | $13.22M | $10.69M | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | $39.11M | $36.08M | $32.40M | $29.08M | $24.66M | $22.11M | $20.17M | $18.48M | – | – |
| International | – | – | – | – | $78.00K | $108.00K | $235.00K | $226.00K | $238.00K | $294.00K | $230.00K | $422.00K | – | – |
From the segment and revenue-disaggregation notes of SANUWAVE Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.